The existence of correlations between the type of MECP2 mutations and the degree of bone impairment in RTT patients [65] and evidence from animal models [36,70,71] point out the possible direct role of MeCP2 in the epigenetic regulation of mediators and pathways related to bone physiology. Here, MECP2 is linked to Rett syndrome.